Articles tagged with Cancer Patients
Scientists have discovered unique mutations on all cancer cells, known as tumour antigens, which can be targeted by the immune system. This breakthrough could lead to more effective immunotherapies and personalized treatment plans for patients with advanced stages of cancer.
A pilot study analyzed 1,516 tweets containing lung cancer-related content, finding that most were about support or prevention, while clinical trials were underrepresented. The study suggests that Twitter may be a useful tool for clinical researchers but also poses challenges related to privacy and noncoercive content.
Researchers found that nearly 18% of lung cancer tweets were about clinical trials, with many focused on immunotherapy. However, none of these tweets were used for recruitment and did not provide links to enrollment websites.
Researchers found that patients with lung and colorectal cancer who had financial distress at diagnosis reported significantly increased pain, symptom burden, and poorer quality of life. The study highlights the need for clinicians to target resources and treatments for patients struggling financially.
A study found that patients with inflammatory bowel disease and a history of cancer did not experience a significant increase in cancer risk when treated with anti-TNF therapy. In fact, 96% of patients were still alive and cancer-free after one year.
Scientists have identified a spectrum of genetic alterations, including some that may be clinically actionable and others that could improve diagnostics and screening for patients. The study's findings suggest targeted therapies and immunotherapies could be effective treatments for mesothelioma.
Researchers have discovered a new biomarker, guanine nucleotide exchange factors (GEFs), that triggers hyperactivity in proteins fueling cancer growth and spread. Elevated GEF expression is associated with shorter progression-free survival in patients with metastatic colorectal cancer.
Researchers at UT Southwestern Medical Center found that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85% accuracy. This technology aims to improve surgical decision-making and reduce the amount of healthy tissue removed during prostate cancer surgery.
A recent study found that over half of elderly colorectal cancer patients receive ineffective treatments, leading to significant financial burdens. The study examined data from over 20,000 Medicare patients between 2000 and 2009, revealing a 32% increase in treatment costs and only a one-month increase in median survival.
The Geographical Management of Cancer Health Disparities Program (GMaP) grant supports region-specific cancer research, education, outreach, and training needs. Moffitt serves as the hub for GMaP Region 2, which includes partner institutions in Alabama, Arkansas, Florida, Georgia, Louisiana, Missouri, Mississippi, and Puerto Rico.
Researchers at H. Lee Moffitt Cancer Center develop adaptive therapy to keep resistant cells in check, prolonging survival without disease progression in mouse models of triple-negative and ER+ breast cancer. The approach is being tested in a clinical trial for prostate cancer patients.
A recent study has found that most US cancer prevention guidelines do not provide sufficient information on benefits and harms, making it difficult for clinicians and patients to make informed decisions. The researchers analyzed data from various guidelines and found that 39% of recommendations were given comparable ratings, while 14.5...
Researchers found that children with ALL who live in high-poverty areas are substantially more likely to experience early relapse, which is harder to treat. Despite receiving the same treatment, these patients have a higher risk of relapse within 36 months after first achieving complete remission.
A study of 105 cancer patients found significant sleep disturbances before radiotherapy treatment. These problems were associated with cancer progression, prior treatments like chemotherapy, and anxiety. Researchers warn that addressing these issues is crucial for improving patient quality of life.
A study published in the JNCI: Journal of the National Cancer Institute found that PET scans did not improve two-year survival rates for lung and esophageal cancer patients. The researchers suggest potential overuse of PET scans in detecting recurrence, warranting efforts to decrease unnecessary utilization.
A study from Lund University in Sweden found that childhood cancer survivors who received certain types of chemotherapy may experience impaired eye movement and balance. The study, which included 23 childhood cancer survivors, compared their eye movement skills to those of healthy individuals of the same age.
A study published in Cancer found that combining chemotherapy with radiation therapy improves survival rates among a subset of elderly head and neck cancer patients, specifically those aged 71 to 79. This improvement was not previously shown in patients older than 70 years.
Uninsured and Medicaid patients with head and neck cancer more likely to present with advanced tumors, experience higher mortality rates. Radiation therapy and surgery used less often for these patients.
Researchers mapped molecular signatures in HPV-positive throat cancer patients based on smoking status. Heavy smokers had higher rates of mutations, including HLA-A and tobacco-exposure associated genes, which predicted poorer survival outcomes. These findings support more aggressive treatment for some patients.
Research found that advanced age, black ethnicity, and pre-existing illnesses like cancer significantly increase the likelihood of bowel obstruction in hospitalized ischemic stroke patients. These complications can worsen recovery chances and lead to increased hospital length of stay and costs.
Researchers at the University of Cincinnati have discovered that a human cancer-causing gene called DEK can be detected in the plasma of head and neck cancer patients. High levels of DEK may indicate better outcomes for patients, while low levels are associated with advanced cancers.
Most recurrences of HPV-positive oropharyngeal cancer can be detected through imaging and physical exams within 6 months after treatment. The study found that disease characteristics, such as lymph node size and number, increase the likelihood of recurrence.
A large-scale analysis of patient records found that chemotherapy before radiation therapy did not improve overall survival rates for head and neck cancer patients. Patients who received concurrent chemotherapy and radiation had slightly longer median overall survival times compared to those receiving chemotherapy alone.
A large-scale analysis of patient records found that induction chemotherapy did not improve overall survival rates or increase the likelihood of receiving a full course of radiation therapy. The study compared more than 8,000 patients who received induction chemotherapy with those who received concurrent chemoradiation.
A combination of durvalumab and tremelimumab has been found to be effective in treating advanced non-small cell lung cancer patients, with 23% achieving a complete or partial response. The treatment also appears to be active in PD-L1-negative tumors.
Colorectal cancer patients require follow-up colonoscopy after surgery to detect second cancers and polyps, with recommended intervals varying from one to nine years. The US Multi-Society Task Force updates guidelines to emphasize the role of colonoscopy in post-surgical surveillance.
Two leading research groups independently discovered ONC201's ability to activate the integrated stress response, a powerful anti-cancer pathway. This understanding supports Oncoceutics' oncology indications and demonstrates ONC201's potential as an important therapeutic.
Researchers found that viewing graphic anti-smoking images on cigarette packs triggers activity in brain areas involved in emotion, decision-making and memory. The findings suggest these images could effectively warn smokers about cigarettes' health consequences and motivate a change in behavior.
Researchers at MD Anderson Cancer Center proposed a new staging system for HPV-related oropharyngeal cancer, which better separates patients with different survival rates. The new groupings were proven to have greater predictive power than the current system, particularly in identifying stage III disease with a high risk of death.
The Cancer Treatment Centers of America is hosting its second Annual New Treatments in Oncology (ANTO) conference on March 5 at the W Scottsdale hotel. The event will feature leading oncologists discussing recent advances and innovations in cancer research, treatment options, and patient care.
A UCLA study reveals that cancer surgery significantly increases the risk of injuries and age-related health issues in older patients, leading to prolonged hospital stays, increased healthcare costs, and a higher risk of death. The study highlights the importance of discussing potential events with doctors before surgery.
A new test has shown that patients with advanced bowel cancer who have high levels of two proteins can benefit from a combination of drugs, leading to improved cancer growth. The test could help select the best treatment for each individual patient, potentially improving survival rates and quality of life.
Cancer patients face financial distress due to rising medication costs, according to Dr. Scott Ramsey's editorial. To address this issue, policy interventions are proposed, including price negotiations with manufacturers and greater transparency of pricing.
Researchers analyze 500 scientific articles to develop a mathematical model for muscle-invasive bladder cancer. They identify potential biomarkers and clinical parameters to accurately determine cancer stage and develop individual treatment strategies.
The Journal of Pain Research publishes commentary on terminology of chronic pain, highlighting the need to redefine terms to better understand and treat patients. The authors suggest using origin- and generator-based terms to improve diagnosis and treatment outcomes.
Researchers found four Ly6 genes are overexpressed in various cancers, leading to poorer survival rates and drug resistance. The study uses big data analysis to identify novel targets for new drugs.
Researchers at Johns Hopkins University found a possible marker for recurring HPV-linked oropharyngeal cancers. The study suggests that an increase in E6 antibody levels after treatment may indicate a higher risk of cancer returning.
A 28-year-old transgender woman experienced a delay in testicular cancer diagnosis due to inadequate access to insurance coverage and transportation challenges. The case study emphasizes the importance of addressing biopsychosocial needs and creating venues for medical providers to learn appropriate care for transgender patients.
A set of risk factors can predict the magnitude of survival benefit offered by radiation therapy following breast cancer surgery. Radiation therapy provides a significant survival benefit for patients with more aggressive cancer, particularly those with higher prognostic scores.
A University of Georgia study found that cancer patients' loved ones search online for information on treatment options and prevention strategies, but are less likely to seek emotional support from social media forums. The study's author aims to use this information to develop effective online cancer prevention messages.
A study published in Gut journal reveals a 10-fold difference in bowel cancer cases and deaths worldwide, with higher incidence linked to economic development. The adoption of a Western lifestyle is suspected to contribute to the rising rates, particularly in low- and middle-income countries.
Men and women in Appalachia continue to have higher cancer incidence rates compared with those in the rest of the United States. Lifestyle changes and improved healthcare are helping narrow the gap between Appalachian and non-Appalachian populations.
The iCat study successfully used clinical genomic sequencing to recommend therapy or diagnose changes in children with solid tumors. The findings support the use of personalized treatment based on tumor genetic characteristics, fueling potential drug development for pediatric and rare adult tumors.
A collection of articles explores fertility issues in patients with cancer, including the legal framework and potential solutions for disputes involving donated genetic material. The articles also highlight the importance of oncologists providing fertility care to their patients.
A study by Baylor College of Medicine found that genetic testing can identify the cause of childhood cancer in 40% of patients, including mutations not previously associated with the disease. The test can also reveal potential clinical targets for treatment and risk of hereditary diseases.
Researchers will test peripherally-restricted cannabinoids (PRCBs) to alleviate oral cancer and chemotherapy-induced neuropathic pain symptoms. The five-year study aims to determine the antitumor potential of PRCBs, their effectiveness against cancer pain, and potential tolerance development.
Research by Michigan Medicine found that nearly 15% of colorectal cancer patients were diagnosed before age 50, often with more advanced disease. Younger patients had better survival rates due to aggressive treatment, suggesting the need for improved long-term survivorship resources.
The American College of Physicians issues guidelines for evaluating blood in the urine as a sign of cancer. Doctors should confirm heme-positive results with microscopic urinalysis before initiating further evaluation in asymptomatic adults. Urology referral is recommended for cystoscopy and imaging in adults with microscopically confi...
A study of US data found that one in seven colorectal cancer patients is younger than 50 years old, often presenting with advanced stage disease. However, these patients tend to receive more aggressive therapy and have a slightly longer survival rate without recurrence.
Researchers found African-American children and adolescents with Hodgkin lymphoma had significantly lower overall survival rates at 25 years compared to their white and Hispanic counterparts. The study, published in Pediatric Blood & Cancer, analyzed data from over 7,800 patients across Florida and the US.
A University of Colorado study found distinct genetic drivers in colorectal cancer among young and old patients, with potential implications for targeted therapies.
Researchers found that a 56-day interval after chemoradiotherapy is the best timeframe for overall survival and tumor downstaging. The study analyzed data from nearly 12,000 patients with advanced stage localized rectal cancer.
A study comparing end-of-life care practices among US, European, and Canadian countries found that the US has lower hospital deaths and days spent in hospitals in the last six months of life. However, it also performs poorly in other aspects of end-of-life care, such as high-tech interventions.
A study found that family members perceive better end-of-life care for patients who received hospice care for longer periods, avoided intensive care unit admissions, and died outside the hospital. These findings suggest that multifaceted approaches can improve preference-sensitive care and overall quality of end-of-life care.
A study of end-of-life care practices in seven developed countries reveals that the US performs poorly in terms of high-tech interventions and hospital utilization. The US has the lowest proportion of deaths in the hospital, but still admits over 40% of cancer patients to the ICU in their last 6 months of life.
A new study uses natural laws to predict how cancers evolve over time, potentially leading to personalized treatment. The research suggests that doctors could use mathematical formulas to anticipate a cancer's growth and development, enabling them to choose the most effective treatments.
A new study suggests that combining PARP inhibitors with c-MET inhibitors may improve treatment outcomes for patients with breast cancer and high c-MET expression levels.
Adolescent girls living in high-poverty communities and majority Hispanic communities were more likely to have received the HPV vaccine. The poverty level of the community was also an important factor, with higher rates found in areas with lower socioeconomic status.
A randomized clinical trial found that ED-initiated palliative care consultations improved quality-of-life scores and median survival without shortening survival. The study suggests that ED visits can provide a unique opportunity for improved access to palliative care.
A thin, stretchable film developed by University of Michigan researchers could enable doctors to catch cancer recurrence earlier with more effective treatment. The film produces circularly polarized light, a crucial ingredient in early warning systems, making it potentially simpler and less expensive to produce.